{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T04:09:36Z","timestamp":1751688576698,"version":"3.41.0"},"reference-count":70,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Susan Komen Foundation","award":["CGPR-2019-TX105-THAC46-00012"],"award-info":[{"award-number":["CGPR-2019-TX105-THAC46-00012"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Purpose<\/jats:title>\n                  <jats:p>Fewer than 20% of underserved individuals undergo guideline-concordant hereditary breast and ovarian cancer (HBOC) genetic testing (GT). Our study aimed to determine the proportion of women eligible for HBOC GT using a cancer genetics risk assessment (CGRA) tool at breast cancer (BC) screening clinics in underserved communities and to describe the program\u2019s impact.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Participants were women who presented for BC screening at The Rose clinics, serving low-income underserved communities in southeast Texas, and completed the CGRA. High-risk individuals received bilingual educational materials and a saliva-based GT kit. Those with a pathogenic variant (PV) or a variant of uncertain significance (VUS) received telegenetic counseling and risk reduction resources.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 501 women completed the CGRA, with 30.1% uninsured. 150 women were identified as eligible for GT, but only 14 (9.9%) completed GT (11 negative, 2 VUS, 1 PV in NF1). GT completion was significantly associated with being White, Native American\/Alaskan Native, and Ashkenazi Jewish (P\u2005&amp;lt;\u2005.05). Hispanic, low-income, and uninsured individuals, or those with fewer relatives with cancer, were as likely to complete GT as others.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>We successfully identified underserved women at high risk of HBOC using CGRA, but the GT completion rate was low. However, the completion rate did not differ by Hispanic ethnicity, income, or insurance status, suggesting that financial navigation by our study coordinator, support from Spanish-language staff at The Rose clinics, and the use of Spanish-language educational materials and translation may have helped overcome some barriers.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/oncolo\/oyaf113","type":"journal-article","created":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T13:03:12Z","timestamp":1751634192000},"source":"Crossref","is-referenced-by-count":0,"title":["Improving genetics equity: identifying women eligible for genetic care services using mammography clinics in underserved areas as screening hubs"],"prefix":"10.1093","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7925-2785","authenticated-orcid":false,"given":"Darya","family":"Kizub","sequence":"first","affiliation":[{"name":"Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center , Houston, TX ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Bluebond","sequence":"additional","affiliation":[{"name":"Department of Clinical Cancer Genetics, The University of Texas MD Anderson Cancer Center , Houston, TX ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sierra","family":"Green","sequence":"additional","affiliation":[{"name":"Department of Clinical Cancer Genetics, The University of Texas MD Anderson Cancer Center , Houston, TX ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Duckworth","sequence":"additional","affiliation":[{"name":"The Rose Center for Breast Health Excellence , Houston, TX ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7705-8185","authenticated-orcid":false,"given":"Sreejesh","family":"Shanker","sequence":"additional","affiliation":[{"name":"Department of Clinical Cancer Genetics, The University of Texas MD Anderson Cancer Center , Houston, TX ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Autumn","family":"Vara","sequence":"additional","affiliation":[{"name":"Department of Clinical Cancer Genetics, The University of Texas MD Anderson Cancer Center , Houston, TX ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5475-8509","authenticated-orcid":false,"given":"Banu","family":"Arun","sequence":"additional","affiliation":[{"name":"Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center , Houston, TX ,","place":["USA"]},{"name":"Department of Clinical Cancer Genetics, The University of Texas MD Anderson Cancer Center , Houston, TX ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,7,4]]},"reference":[{"key":"2025070409030828700_CIT0001","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"2025070409030828700_CIT0002","author":"NCCN Clinical Practice Guidelines in Oncology"},{"key":"2025070409030828700_CIT0003","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1001\/jama.2014.17322","article-title":"Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States","volume":"313","author":"Iqbal","year":"2015","journal-title":"JAMA"},{"key":"2025070409030828700_CIT0004","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1097\/EDE.0000000000001394","article-title":"Recent changes in the patterns of breast cancer as a proportion of all deaths according to race and ethnicity","volume":"32","author":"Trentham-Dietz","year":"2021","journal-title":"Epidemiology"},{"key":"2025070409030828700_CIT0005","doi-asserted-by":"publisher","first-page":"pkz084","DOI":"10.1093\/jncics\/pkz084","article-title":"Race, socioeconomic status, and health-care access disparities in ovarian cancer treatment and mortality: systematic review and meta-analysis","volume":"3","author":"Karanth","year":"2019","journal-title":"JNCI Cancer Spectr"},{"key":"2025070409030828700_CIT0006","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1111\/1468-0009.12355","article-title":"Disparities in breast cancer survival by socioeconomic status despite medicare and medicaid insurance","volume":"96","author":"Silber","year":"2018","journal-title":"Milbank Q"},{"key":"2025070409030828700_CIT0007","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1001\/jama.2019.10987","article-title":"Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer: US preventive services task force recommendation statement","volume":"322","author":"Owens","year":"2019","journal-title":"JAMA"},{"key":"2025070409030828700_CIT0008","doi-asserted-by":"publisher","first-page":"380","DOI":"10.6004\/jnccn.2020.0017","article-title":"NCCN Guidelines insights: genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 1.2020: featured updates to the NCCN guidelines","volume":"18","author":"Daly","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"key":"2025070409030828700_CIT0009","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/GIM.0b013e31818fa2ff","article-title":"Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives","volume":"11","author":"Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group: Alfred O Berg, Katrina Armstrong, Jeffrey Botkin, Ned Calonge, James Haddow, Maxine Hayes, Celia Kaye, Kathryn A Phillips, Margaret Piper, Carolyn Sue Richards, Joan A Scott, Ora L Strickland, Steven Teutsch","year":"2009","journal-title":"Genet Med"},{"key":"2025070409030828700_CIT0010","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/DCR.0000000000000785","article-title":"Clinical practice guidelines for the surgical treatment of patients with lynch syndrome","volume":"60","author":"Herzig","year":"2017","journal-title":"Dis Colon Rectum"},{"key":"2025070409030828700_CIT0011","doi-asserted-by":"publisher","first-page":"e460","DOI":"10.1200\/JOP.2014.003558","article-title":"Breast cancer risk assessment among low-income women of color in primary care: a Pilot Study","volume":"11","author":"Anderson","year":"2015","journal-title":"J Oncol Pract"},{"key":"2025070409030828700_CIT0012","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/jgc4.1262","article-title":"Public perception of predictive cancer genetic testing and research in Oregon","volume":"29","author":"Alvord","year":"2020","journal-title":"J Genet Couns"},{"key":"2025070409030828700_CIT0013","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1158\/1055-9965.EPI-12-1280","article-title":"Prevalence and healthcare actions of women in a large health system with a family history meeting the 2005 USPSTF recommendation for BRCA genetic counseling referral","volume":"22","author":"Bellcross","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2025070409030828700_CIT0014","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1200\/JCO.2013.51.4661","article-title":"Quality of cancer family history and referral for genetic counseling and testing among oncology practices: a pilot test of quality measures as part of the American Society of Clinical Oncology Quality Oncology Practice Initiative","volume":"32","author":"Wood","year":"2014","journal-title":"J Clin Oncol"},{"key":"2025070409030828700_CIT0015","doi-asserted-by":"publisher","first-page":"885","DOI":"10.3122\/jabfm.2020.06.190461","article-title":"BRCA-related cancer genetic counseling is indicated in many women seeking primary care","volume":"33","author":"Parente","year":"2020","journal-title":"J Am Board Fam Med"},{"key":"2025070409030828700_CIT0016","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1200\/JCO.18.01854","article-title":"Genetic testing and results in a population-based cohort of breast cancer patients and ovarian cancer patients","volume":"37","author":"Kurian","year":"2019","journal-title":"J Clin Oncol"},{"key":"2025070409030828700_CIT0017","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1158\/1055-9965.EPI-13-1380","article-title":"A randomized, controlled trial to increase discussion of breast cancer in primary care","volume":"23","author":"Kaplan","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2025070409030828700_CIT0018","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1097\/00001888-200008000-00021","article-title":"Knowledge, attitudes, and behaviors of Alabama\u2019s primary care physicians regarding cancer genetics","volume":"75","author":"Acton","year":"2000","journal-title":"Acad Med"},{"key":"2025070409030828700_CIT0019","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/ajmg.a.10192","article-title":"US physicians\u2019 attitudes toward genetic testing for cancer susceptibility","volume":"120A","author":"Freedman","year":"2003","journal-title":"Am J Med Genet A"},{"key":"2025070409030828700_CIT0020","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1136\/jmg.2004.018234","article-title":"Effects of a cancer genetics education programme on clinician knowledge and practice","volume":"41","author":"Blazer","year":"2004","journal-title":"J Med Genet"},{"key":"2025070409030828700_CIT0021","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1111\/j.1572-0241.2003.07481.x","article-title":"Colorectal cancer screening and familial risk: a survey of internal medicine residents\u2019 knowledge and practice patterns","volume":"98","author":"Barrison","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"2025070409030828700_CIT0022","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1023\/b:fame.0000004597.29811.8e","article-title":"Swiss primary care physicians\u2019 knowledge, attitudes and perception towards genetic testing for hereditary breast cancer","volume":"2","author":"Pichert","year":"2003","journal-title":"Fam Cancer"},{"key":"2025070409030828700_CIT0023","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.amepre.2010.09.027","article-title":"Awareness and utilization of BRCA1\/2 testing among U.S. primary care physicians","volume":"40","author":"Bellcross","year":"2011","journal-title":"Am J Prev Med"},{"key":"2025070409030828700_CIT0024","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s11606-019-05469-7","article-title":"Calling on primary care to prevent d cancers","volume":"35","author":"Armstrong","year":"2020","journal-title":"J Gen Intern Med"},{"key":"2025070409030828700_CIT0025","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/gim.2012.168","article-title":"Primary-care physicians\u2019 access to genetic specialists: an impediment to the routine use of genomic medicine","volume":"15","author":"Haga","year":"2013","journal-title":"Genet Med"},{"key":"2025070409030828700_CIT0026","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/gim.2015.179","article-title":"Expanding the genetic counseling workforce: program directors\u2019 views on increasing the size of genetic counseling graduate programs","volume":"18","author":"Pan","year":"2016","journal-title":"Genet Med"},{"key":"2025070409030828700_CIT0027","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1093\/jnci\/djaa042","article-title":"Genetic testing may help reduce breast cancer disparities for African American Women","volume":"112","author":"McCarthy","year":"2020","journal-title":"J Natl Cancer Inst"},{"key":"2025070409030828700_CIT0028","doi-asserted-by":"publisher","first-page":"106257","DOI":"10.1016\/j.cct.2020.106257","article-title":"Design of a study to implement population-based risk assessment for hereditary cancer genetic testing in primary care","volume":"101","author":"Bowen","year":"2021","journal-title":"Contemp Clin Trials"},{"key":"2025070409030828700_CIT0029","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1186\/s12913-021-06489-y","article-title":"Comparing models of delivery for cancer genetics services among patients receiving primary care who meet criteria for genetic evaluation in two healthcare systems: BRIDGE randomized controlled trial","volume":"21","author":"Kaphingst","year":"2021","journal-title":"BMC Health Serv Res"},{"key":"2025070409030828700_CIT0030","doi-asserted-by":"publisher","first-page":"106432","DOI":"10.1016\/j.cct.2021.106432","article-title":"Cancer Health Assessments Reaching Many (CHARM): a clinical trial assessing a multimodal cancer genetics services delivery program and its impact on diverse populations","volume":"106","author":"Mittendorf","year":"2021","journal-title":"Contemp Clin Trials"},{"key":"2025070409030828700_CIT0031","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.cct.2018.09.005","article-title":"Promoting guideline-based cancer genetic risk assessment for hereditary breast and ovarian cancer in ethnically and geographically diverse cancer survivors: Rationale and design of a 3-arm randomized controlled trial","volume":"73","author":"Kinney","year":"2018","journal-title":"Contemp Clin Trials"},{"key":"2025070409030828700_CIT0032","article-title":"Behavioral Risk Factor Surveillance System","volume-title":"StatPearls","author":"Rolle-Lake","year":"2022"},{"key":"2025070409030828700_CIT0033","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/cncr.33866","article-title":"Increasing referral of at-risk women for genetic counseling and BRCA testing using a screening tool in a community breast imaging center","volume":"128","author":"Arun","year":"2021","journal-title":"Cancer"},{"key":"2025070409030828700_CIT0034","doi-asserted-by":"publisher","first-page":"dju328","DOI":"10.1093\/jnci\/dju328","article-title":"Expanding access to BRCA1\/2 genetic counseling with telephone delivery: a cluster randomized trial","volume":"106","author":"Kinney","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"2025070409030828700_CIT0035","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1200\/JCO.2013.51.3226","article-title":"Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer","volume":"32","author":"Schwartz","year":"2014","journal-title":"J Clin Oncol"},{"key":"2025070409030828700_CIT0036","doi-asserted-by":"publisher","first-page":"4532","DOI":"10.1002\/cam4.3968","article-title":"Randomized study of remote telehealth genetic services versus usual care in oncology practices without genetic counselors","volume":"10","author":"Cacioppo","year":"2021","journal-title":"Cancer Med"},{"key":"2025070409030828700_CIT0037","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1200\/jco.2020.38.15_suppl.1506","article-title":"Results from MAGENTA: a national randomized four-arm noninferiority trial evaluating pre- and post-test genetic counseling during online testing for breast and ovarian cancer genetic risk","volume":"38","author":"Swisher","year":"2020","journal-title":"J Clin Oncol"},{"key":"2025070409030828700_CIT0038","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1007\/s10897-016-0050-y","article-title":"Breast cancer risk assessment at the time of screening mammography: perceptions and clinical management outcomes for women at high risk","volume":"26","author":"Morman","year":"2017","journal-title":"J Genet Couns"},{"key":"2025070409030828700_CIT0039","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1097\/GIM.0b013e3181b9b04a","article-title":"Evaluation of a breast\/ovarian cancer genetics referral screening tool in a mammography population","volume":"11","author":"Bellcross","year":"2009","journal-title":"Genet Med"},{"key":"2025070409030828700_CIT0040","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1002\/cncr.21393","article-title":"Prevalence of hereditary breast\/ovarian carcinoma risk in patients with a personal history of breast or ovarian carcinoma in a mammography population","volume":"104","author":"Dominguez","year":"2005","journal-title":"Cancer"},{"key":"2025070409030828700_CIT0041","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/gim.2014.68","article-title":"Characteristics associated with genetic counseling referral and BRCA1\/2 testing among women in a large integrated health system","volume":"17","author":"Bellcross","year":"2015","journal-title":"Genet Med"},{"key":"2025070409030828700_CIT0042","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1200\/JOP.19.00221","article-title":"Decision making about genetic testing among women with a personal and family history of breast cancer","volume":"16","author":"Scott","year":"2020","journal-title":"JCO Oncol Pract"},{"key":"2025070409030828700_CIT0043","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1158\/1055-9965.EPI-17-0389","article-title":"Genetic testing in a population-based sample of breast and ovarian cancer survivors from the REACH Randomized Trial: cost barriers and moderators of counseling mode","volume":"26","author":"Steffen","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2025070409030828700_CIT0044","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1897-4287-9-2","article-title":"Factors influencing cancer risk perception in high risk populations: a systematic review","volume":"9","author":"Tilburt","year":"2011","journal-title":"Hered Cancer Clin Pract"},{"key":"2025070409030828700_CIT0045","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1037\/\/0278-6133.9.6.792","article-title":"Risk perceptions and participation in colorectal cancer screening","volume":"9","author":"Blalock","year":"1990","journal-title":"Health Psychol"},{"key":"2025070409030828700_CIT0046","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s10897-016-0064-5","article-title":"Large, prospective analysis of the reasons patients do not pursue BRCA genetic testing following genetic counseling","volume":"26","author":"Hayden","year":"2017","journal-title":"J Genet Couns"},{"key":"2025070409030828700_CIT0047","doi-asserted-by":"publisher","first-page":"209","DOI":"10.12788\/jcso.0050","article-title":"Short-term outcomes of the implementation of a computer-based breast cancer risk assessment program during screening mammography","volume":"12","author":"Ray","year":"2014","journal-title":"J Commun Support Oncol"},{"key":"2025070409030828700_CIT0048","doi-asserted-by":"publisher","first-page":"3509","DOI":"10.1002\/cncr.30190","article-title":"The effect of referral for genetic counseling on genetic testing and surgical prevention in women at high risk for ovarian cancer: Results from a randomized controlled trial","volume":"122","author":"Drescher","year":"2016","journal-title":"Cancer"},{"key":"2025070409030828700_CIT0049","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.1007\/s11606-021-07216-3","article-title":"\u201cPatient Lost to Follow-up\u201d: opportunities and challenges in delivering primary care in academic medical centers","volume":"37","author":"Amat","year":"2022","journal-title":"J Gen Intern Med"},{"key":"2025070409030828700_CIT0050","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s11606-010-1334-9","article-title":"Familial risk of cancer and knowledge and use of genetic testing","volume":"25","author":"Baer","year":"2010","journal-title":"J Gen Intern Med"},{"key":"2025070409030828700_CIT0051","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/gim.2014.125","article-title":"Disparities in uptake of BRCA1\/2 genetic testing in a randomized trial of telephone counseling","volume":"17","author":"Butrick","year":"2015","journal-title":"Genet Med"},{"key":"2025070409030828700_CIT0052","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1007\/s40615-018-00556-7","article-title":"Racial\/ethnic disparities in BRCA counseling and testing: a narrative review","volume":"6","author":"Williams","year":"2019","journal-title":"J Racial Ethn Health Disparities"},{"key":"2025070409030828700_CIT0053","first-page":"1251","article-title":"Factors associated with decisions about clinical BRCA1\/2 testing","volume":"9","author":"Armstrong","year":"2000","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2025070409030828700_CIT0054","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1002\/cncr.10420","article-title":"Utilization of BRCA1\/2 genetic testing in the clinical setting: report from a single institution","volume":"94","author":"Lee","year":"2002","journal-title":"Cancer"},{"key":"2025070409030828700_CIT0055","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s12609-020-00364-1","article-title":"Disparities in genetic testing and care among black women with hereditary breast cancer","volume":"12","author":"Reid","year":"2020","journal-title":"Curr Breast Cancer Rep"},{"key":"2025070409030828700_CIT0056","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.jnma.2020.09.146","article-title":"African-Americans are less frequently assessed for hereditary colon cancer","volume":"113","author":"Garland","year":"2021","journal-title":"J Natl Med Assoc"},{"key":"2025070409030828700_CIT0057","doi-asserted-by":"publisher","first-page":"351","DOI":"10.6004\/jnccn.2022.7257","article-title":"Nationwide trends and determinants of germline BRCA1\/2 testing in patients with breast and ovarian cancer","volume":"21","author":"Lau-Min","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"key":"2025070409030828700_CIT0058","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1200\/JCO.2015.66.0019","article-title":"Health care segregation, physician recommendation, and racial disparities in BRCA1\/2 testing among women with breast cancer","volume":"34","author":"McCarthy","year":"2016","journal-title":"J Clin Oncol"},{"key":"2025070409030828700_CIT0059","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1002\/jgc4.1439","article-title":"The role of psychosocial factors in Black women\u2019s self-efficacy in receiving genetic counseling and testing","volume":"30","author":"Ding","year":"2021","journal-title":"J Genet Couns"},{"key":"2025070409030828700_CIT0060","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/s0027-9684(15)30081-x","article-title":"Medical mistrust influences black women\u2019s level of engagement in BRCA 1\/2 genetic counseling and testing","volume":"105","author":"Sheppard","year":"2013","journal-title":"J Natl Med Assoc"},{"key":"2025070409030828700_CIT0061","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1186\/s12913-022-08193-x","article-title":"Pilot study of a culturally sensitive intervention to promote genetic counseling for breast cancer risk","volume":"22","author":"Henderson","year":"2022","journal-title":"BMC Health Serv Res"},{"key":"2025070409030828700_CIT0062","doi-asserted-by":"publisher","first-page":"107210","DOI":"10.1016\/j.cct.2023.107210","article-title":"Addressing disparities in the uptake of genetic counseling and testing in African American women; rationale, design and methods","volume":"130","author":"Sheppard","year":"2023","journal-title":"Contemp Clin Trials"},{"key":"2025070409030828700_CIT0063","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.cancergen.2019.04.063","article-title":"Uptake of genetic testing for germline BRCA1\/2 pathogenic variants in a predominantly Hispanic population","volume":"235-236","author":"McGuinness","year":"2019","journal-title":"Cancer Genet"},{"key":"2025070409030828700_CIT0064","doi-asserted-by":"publisher","first-page":"e1982","DOI":"10.1002\/onco.13968","article-title":"Implementation of an embedded in-clinic genetic testing station to optimize germline testing for patients with pancreatic adenocarcinoma","volume":"26","author":"Walker","year":"2021","journal-title":"Oncologist"},{"key":"2025070409030828700_CIT0065","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s12687-019-00423-w","article-title":"Developing a culturally targeted video to enhance the use of genetic counseling in Latina women at increased risk for hereditary breast and ovarian cancer","volume":"11","author":"Hurtado-de-Mendoza","year":"2020","journal-title":"J Commun Genet"},{"key":"2025070409030828700_CIT0066","doi-asserted-by":"publisher","first-page":"4793","DOI":"10.3390\/ijerph16234793","article-title":"Culturally targeted video improves psychosocial outcomes in Latina women at risk of hereditary breast and ovarian cancer","volume":"16","author":"Hurtado-de-Mendoza","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"2025070409030828700_CIT0067","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/jgc4.1324","article-title":"A pilot randomized trial of an educational intervention to increase genetic counseling and genetic testing among Latina breast cancer survivors","volume":"30","author":"Conley","year":"2021","journal-title":"J Genet Couns"},{"key":"2025070409030828700_CIT0068","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1002\/jgc4.1793","article-title":"Promotores\u2019 perspectives on the virtual adaptation of a hereditary breast cancer education program","volume":"32","author":"Perez","year":"2023","journal-title":"J Genet Couns"},{"key":"2025070409030828700_CIT0069","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.1016\/j.amepre.2020.08.029","article-title":"Initiatives to scale up and expand reach of cancer genomic services outside of specialty clinical settings: a systematic review","volume":"60","author":"Guan","year":"2021","journal-title":"Am J Prev Med"},{"key":"2025070409030828700_CIT0070","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.2105\/ajph.89.9.1322","article-title":"Evaluating the public health impact of health promotion interventions: the RE-AIM framework","volume":"89","author":"Glasgow","year":"1999","journal-title":"Am J Public Health"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/30\/7\/oyaf113\/63669872\/oyaf113.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/30\/7\/oyaf113\/63669872\/oyaf113.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T13:03:13Z","timestamp":1751634193000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/doi\/10.1093\/oncolo\/oyaf113\/8186019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":70,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7,4]]}},"URL":"https:\/\/doi.org\/10.1093\/oncolo\/oyaf113","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,7]]},"published":{"date-parts":[[2025,7]]}}}